Ayala Pharmaceuticals Inc (ADXS)

[mpreorder]

There is something unappreciated about the Sellas deal. You see, the WT1 antigen is already in clinical trials, and it already has had success in those trials. So essentially, Sellas took a look at what Advaxis is doing, told their science boys to take a look and see if they could further the success of this antigen using Lm tech, and ponied up big bucks when they decided it was worth it to try. This is not an antigen that Advaxis was developing, but one of another company. So the question we should be asking now is: How many other companies developing cancer vaccines with their own antigens are considering using Lm technology? Perhaps it is even likely that some are already in discussion with Advaxis? It's also likely this deal with Sellas will cause other companies to take a look at Lm tech much more closely.
I took a quick look at the WT1 antigen - this came up on Wiki:
"WT1 has been ranked by the National Cancer Institute (NCI) as the Number 1 target for cancer immunotherapy.[18][19]"

I believe this deal to be much, much more than it appears on the surface. It's likely this deal is one of many to come. The writing is on the wall folks, plain as day to those who can read. Anyone shorting is nuts, anyone selling will be missing out on the opportunity of a lifetime, and anyone not buying all they can afford is overestimating the risk. To me this is just a waiting game now.